Trials / Recruiting
RecruitingNCT06607731
Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collecting data from medical records | Data collected: clinical data (particularly pain), biological data, imaging. |
Timeline
- Start date
- 2024-06-25
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2024-09-23
- Last updated
- 2024-10-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06607731. Inclusion in this directory is not an endorsement.